| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Surgery For Morbid Obesity Is Not Simply About Losing Weight |
|
E-Articles - Surgery For Morbid Obesity Is Not Simply About Losing Weight
Obesity in the United States more than doubled in the last 30 years of the twentieth century and in the first few years of this century it has truly taken off with a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n estimated 15 million Americans now being classed as severely or morbidly obese. Although the United States leads the world in terms of obesity, the picture globall ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y is far from good and the World Health Organization now considers obesity to be a global epidemic. The number of deaths from obesity in the United States, which co lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ntinues to rise annually, had reached a staggering 400,000 by the turn of the century and this places obesity only a short head behind smoking which remains the numb here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe er one killer in America today. As obesity continues to grow an increasing number of people are turning to surgery for morbid obesity as the cure for their weight p d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro roblem. Surgery is not however an easy option, even with the introduction of simpler surgical techniques such as laparoscopic adjustable gastric banding approved for ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc use in the US by the FDA in June 2001. It is nevertheless an effective solution and can not only produce dramatic weight loss in a relatively short space of time bu easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t can also allow patients to maintain their weight loss – something that traditional diet and exercise simple does not achieve. The problem however is that obesity nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically is seen very much as a problem of weight and surgery is viewed very much as a form of radical but effective diet. Doctors insist that patients try a regime of diet a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nd exercise before embarking on surgery, as do the insurance companies, and it is only when a normal diet program fails that they turn to the more drastic surgical d ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi iet. This is all well and good, but it seems to miss the central point at issue. Being overweight doesn't kill you! People do not die because they are overweight. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a They die because being overweight places a strain on the body and gives rise to a variety of conditions such as type 2 diabetes, hypertension, sleep apnea and liver dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod disease which can result in death. Now if you are admitted to hospital with coronary heart disease and the doctors recommend heart surgery as your best or only opti cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin on nobody, including your insurance company, is going to question the surgeon's recommendation. But, if you are severely obese and go into hospital with hypertension tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen which your doctor feels will almost certainly lead to coronary artery disease if not treated and recommends surgery to cure your severe obesity, and consequently re t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel lieve your hypertension, everybody is going to hold up there hands and say "hang on a minute all we need here is a regime of diet and exercise". As a society we ten ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d to view obesity as being something of a "personal problem" which most people could have avoided if they had taken better care of themselves. Weight loss surgery is y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products also all too often viewed as a "cosmetic" procedure designed to make people look and feel better and to allow them to get back to leading the active and enjoyable l . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ifestyle which they enjoyed before they put on so much weight. It is all too easy to ignore the fact that we as a society have created many of the conditions which elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip all too frequently lead to obesity and that those suffering from severe obesity face the very real possibility of death without the ability to get the help they need tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Rural Michigan - Building a New Industry Guide to Getting Small Business Grants The Teacher Advancement Program at Cincinnati Schools Seeks to Keep Good Teachers
|